Adi Print Solutions

Closed
Call
Website

Photos

12 Channel St Ste 801
Boston, MA 02210
+1 (617) 466-1944
https://digitalprintboston.com

ADI Print Solutions, located in Boston, MA, has been providing exceptional digital on-demand print services for over 20 years, serving Greater Boston and beyond. Their extensive range of products includes custom invitations, stationery, posters, promotional items, and more, catering to various business and personal needs.

With a commitment to quality and customer satisfaction, ADI Print Solutions offers tailored solutions for direct mail, marketing materials, and event programs. Their expertise ensures that clients can effectively promote their brands and communicate with their audiences through high-quality printed materials.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Boston Business Printing
Business services, nec, nec, Business forms: printing, nsk, Forms, business: gravure printing

Boston Business Printing

48
"It exceeded my expectations for printing on a short notice. They helped me printing a book for my graphic design class. Overall awesome job! The process took 3 days. They were all very patient..."
photo of Charlene Y.
Printers and plotters: computers, Blueprinting service, Promotional printing, lithographic

Chase Graphics

1
"Needed some magnets to put on a few of our vehicles to advertise a community event/fundraiser for The Lions Club. Not only did they make the magnets quickly but the layout, coloring and lettering..."
photo of Tina S.
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
United States›Massachusetts›Boston›Adi Print Solutions

Partial Data by Infogroup (c) 2025. All rights reserved.